179 related articles for article (PubMed ID: 18694944)
1. Metronidazole lacks antibacterial activity in guinea pigs infected with Mycobacterium tuberculosis.
Hoff DR; Caraway ML; Brooks EJ; Driver ER; Ryan GJ; Peloquin CA; Orme IM; Basaraba RJ; Lenaerts AJ
Antimicrob Agents Chemother; 2008 Nov; 52(11):4137-40. PubMed ID: 18694944
[TBL] [Abstract][Full Text] [Related]
2. Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.
Lenaerts AJ; Hoff D; Aly S; Ehlers S; Andries K; Cantarero L; Orme IM; Basaraba RJ
Antimicrob Agents Chemother; 2007 Sep; 51(9):3338-45. PubMed ID: 17517834
[TBL] [Abstract][Full Text] [Related]
3. Experimental ocular tuberculosis in guinea pigs.
Rao NA; Albini TA; Kumaradas M; Pinn ML; Fraig MM; Karakousis PC
Arch Ophthalmol; 2009 Sep; 127(9):1162-6. PubMed ID: 19752425
[TBL] [Abstract][Full Text] [Related]
4. Bacteriologic basis of short-course chemotherapy for tuberculosis.
Grosset J
Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
[No Abstract] [Full Text] [Related]
5. Delamanid Kills Dormant Mycobacteria
Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
[TBL] [Abstract][Full Text] [Related]
6. The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Jindani A; Aber VR; Edwards EA; Mitchison DA
Am Rev Respir Dis; 1980 Jun; 121(6):939-49. PubMed ID: 6774638
[No Abstract] [Full Text] [Related]
7. Evaluation of standard chemotherapy in the guinea pig model of tuberculosis.
Ordway DJ; Shanley CA; Caraway ML; Orme EA; Bucy DS; Hascall-Dove L; Henao-Tamayo M; Harton MR; Shang S; Ackart D; Kraft SL; Lenaerts AJ; Basaraba RJ; Orme IM
Antimicrob Agents Chemother; 2010 May; 54(5):1820-33. PubMed ID: 20160055
[TBL] [Abstract][Full Text] [Related]
8. Impact of the interaction of R207910 with rifampin on the treatment of tuberculosis studied in the mouse model.
Lounis N; Gevers T; Van Den Berg J; Andries K
Antimicrob Agents Chemother; 2008 Oct; 52(10):3568-72. PubMed ID: 18644960
[TBL] [Abstract][Full Text] [Related]
9. Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.
De Groote MA; Gruppo V; Woolhiser LK; Orme IM; Gilliland JC; Lenaerts AJ
Antimicrob Agents Chemother; 2012 Feb; 56(2):731-8. PubMed ID: 22143517
[TBL] [Abstract][Full Text] [Related]
10. Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model.
de Knegt GJ; Dickinson L; Pertinez H; Evangelopoulos D; McHugh TD; Bakker-Woudenberg IAJM; Davies GR; de Steenwinkel JEM
Tuberculosis (Edinb); 2017 Jul; 105():113-118. PubMed ID: 28610782
[TBL] [Abstract][Full Text] [Related]
11. The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Iacobino A; Giannoni F; Pardini M; Piccaro G; Fattorini L
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010861
[TBL] [Abstract][Full Text] [Related]
12. Improved Mycobacterium tuberculosis clearance after the restoration of IFN-γ
Kamboj D; Gupta P; Basil MV; Mohan A; Guleria R; Bhatnagar A; Mehta G; Kumar P; Saurabh A; Deepak R; Thakral D; Misra P; Tandon R; Gupta UD; Mitra DK
Eur J Immunol; 2020 May; 50(5):736-747. PubMed ID: 32113187
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo.
Harth G; Horwitz MA
Infect Immun; 2003 Jan; 71(1):456-64. PubMed ID: 12496196
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
[TBL] [Abstract][Full Text] [Related]
15. A guinea pig model of experimental airborne tuberculosis for evaluation of the response to chemotherapy: the effect on bacilli in the initial phase of treatment.
Smith DW; Balasubramanian V; Wiegeshaus E
Tubercle; 1991 Sep; 72(3):223-31. PubMed ID: 1771684
[TBL] [Abstract][Full Text] [Related]
16. Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models.
Lenaerts AJ; Gruppo V; Marietta KS; Johnson CM; Driscoll DK; Tompkins NM; Rose JD; Reynolds RC; Orme IM
Antimicrob Agents Chemother; 2005 Jun; 49(6):2294-301. PubMed ID: 15917524
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.
Somoskovi A; Parsons LM; Salfinger M
Respir Res; 2001; 2(3):164-8. PubMed ID: 11686881
[TBL] [Abstract][Full Text] [Related]
18. Treatment of tuberculosis. The Mitchell lecture 1979.
Mitchison DA
J R Coll Physicians Lond; 1980 Apr; 14(2):91-5, 98-9. PubMed ID: 6767845
[No Abstract] [Full Text] [Related]
19. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z
Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro].
Golyshevskaia VI; Selishcheva AA; Martynova LP; Lepekha LN; Kalashnikova TM; Kornilova ZKh; Erokhin VV; Rozenberg OA
Probl Tuberk Bolezn Legk; 2006; (8):61-4. PubMed ID: 17002062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
